Cowen And Company, LLC Syndax Pharmaceuticals Inc Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $5,594 - $8,350	-377 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $5,741 - $8,471	377 New	377 $8,000
Q4 2020 Feb 08, 2021	SELL	$15.1 - $26.44 $195,484 - $342,292	-12,946 Closed	0 $0
Q3 2020 Nov 03, 2020	SELL	$13.39 - $17.48 $177,738 - $232,029	-13,274 Reduced 50.63%	12,946 $191,000
Q2 2020 Aug 13, 2020	BUY	$8.94 - $20.98 $234,406 - $550,095	26,220 New	26,220 $389,000

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.